Strategic Partnerships Merger with TRU Biologix expands biologics and regenerative medicine portfolio, creating cross-selling opportunities with NeoGen Plasma to aesthetic clinics and medspas; align sales motion around bundles of energy-based devices with regenerative therapies.

Regenerative Growth NeoGen Plasma is flagship device with award-winning results and regenerative properties; position to clinics focusing on minimally invasive aesthetics; prospect list includes dermatology practices, cosmetic surgeons, medspas seeking high ROI devices; potential to upsell TRU Biologix biologic offerings.

Market Opportunity Aesthetic medical devices with energy-based platforms are growing; small innovator status in US market allows rapid onboarding of clinics; leverage merger to demonstrate expanded, one-stop solutions for regenerative and energy-based treatments.

Geographic Expansion Based in Hudson NH, national expansion can be pursued via partnerships with larger distributors and via TRU Biologix network; target regional dermatology and plastic surgery chains, medspa groups.

Digital Enablement Current web technology stack supports digital marketing and lead capture; optimize content and webinars to educate prospects on ROI, patient outcomes, and integrated solutions; propose training programs and after-sales support to boost adoption.